{"mainPropery":{"diseaseId":10420,"diseaseName":"Neurofibromatosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10420/neurofibromatosis","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C0162678"}]},"diseaseCategories":[],"organizations":[{"resourceID":16,"resourceName":"Children's Tumor Foundation","abbreviation":"CTF","address1":"120 Wall Street, 16th floor","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10005-3904","country":"United States","phone":"+1-212-344-6633","tty":"","tollFree":"1-800-323-7938","fax":"+1-212-747-0004","email":"info@ctf.org","url":"https://www.ctf.org/","freeText":""},{"resourceID":33,"resourceName":"Neurofibromatosis Network","abbreviation":"","address1":"213 S. Wheaton Ave.","address2":"","address3":"","address4":"","address5":"","city":"Wheaton","state":"IL","zip":"60187","country":"United States","phone":"+1-630-510-1115","tty":"","tollFree":"1-800-942-6825","fax":"+1-630-510-8505","email":"admin@nfnetwork.org","url":"https://www.nfnetwork.org/","freeText":""},{"resourceID":932,"resourceName":"March of Dimes","address1":"1275 Mamaroneck Avenue","city":"White Plains","state":"NY","zip":"10605","country":"United States","phone":"914-997-4488","tollFree":"888-663-4637","fax":"914-997-4763","email":"http://www.marchofdimes.com/contactus.html","url":"http://www.marchofdimes.com/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=omim&Cmd=DetailsSearch&Term=neurofibromatosis%5Bti%5D' target='_blank'>The Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=neurofibromatosis%5Btitle%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neurofibromatosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Neurofibromatosis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Neurofibromatosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":659,"resourceId":1371,"resourceName":"Neurofibromatosis Find a Doctor","descriptionText":"The <a href='https://www.nfnetwork.org//understand-nf/find-doctor/' target='_blank'>Neurofibromatosis Network</a> provides a tool for locating a neurofibromatosis specialist in your area. Click on Neurofibromatosis Network to access the tool.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/neurofibromatosis.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/neurofibromatosis/detail_neurofibromatosis.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n<a href='https://www.ncbi.nlm.nih.gov/books/NBK1109/' target='_blank'>Neurofibromatosis type 1</a><br /><a href='https://www.ncbi.nlm.nih.gov/books/NBK1201/' target='_blank'>Neurofibromatosis type 2</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1538,"resourceId":2169,"resourceName":"MeSH®","descriptionText":"<a href='http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&index=16251&view=expanded' target='_blank'>MeSH®</a> (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1549,"resourceId":2177,"resourceName":"National Human Genome Research Institute","descriptionText":"The <a href='http://www.genome.gov/14514225' target='_blank'>National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/systemic/neurofibromatosis.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1590,"resourceId":2202,"resourceName":"Neurofibromatoses and RASopathies: Their Management, Diagnosis, Current and Future Therapeutic Avenues","descriptionText":"<a href='http://ras-pathway-syndromes.com/content/neurofibromatoses-and-rasopathies' target='_blank'>Neurofibromatoses and RASopathies: Their Management, Diagnosis, Current and Future Therapeutic Avenues</a> &lt;br /&gt;\r\nMonday, September 30, 2013 - Tuesday, October 01, 2013 &lt;br /&gt;\r\n&lt;strong&gt;Location:&lt;/strong&gt; Radisson Blu Hotel, Cardiff, Wales &lt;br /&gt;\r\n&lt;strong&gt;Description:&lt;/strong&gt; This international meeting will provide a most comprehensive and up to date account of recent developments in this field. Internationally recognized experts from the UK, Europe and the USA will speak on neurofibromatoses and rasopathies. This meeting will be suitable for medical geneticists, oncologists, dermatologists, neurologists, endocrinologists, psychiatrists, molecular and cellular biologists, genetic counsellors and general practitioners.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:8712' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Neurofibromatosis. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Neurofibromatosis:<br />\r\n<a href='https://nfregistry.patientcrossroads.org/' target='_blank'>NF Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":3019,"questionText":"What is neurofibromatosis?","answerText":"<strong>Neurofibromatosis</strong> (NF) is a genetic disease that causes tumors to develop in the <a href=\"http://ghr.nlm.nih.gov/glossary=nervoussystem\" target=\"_blank\">nervous system</a>.[7943] There are three types of neurofibromatosis that are each associated with unique signs and symptoms:[7943][2019][7942]\r\n<ul>\r\n    <li><a href=\"http://rarediseases.info.nih.gov/GARD/Condition/7866/NF1.aspx\" target=\"_blank\">Neurofibromatosis type 1</a> (NF1) causes skin changes (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/2447.htm\" target=\"_blank\">cafe-au-lait spots</a>, freckling in armpit and groin area); bone abnormalities; <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001024.htm\" target=\"_blank\">optic gliomas</a>; and tumors on the nerve tissue or under the skin. Signs and symptoms are usually present at birth.\r\n    </li>\r\n</ul>\r\n<ul>\r\n    <li><a href=\"http://rarediseases.info.nih.gov/GARD/Condition/7193/NF_2.aspx\" target=\"_blank\">Neurofibromatosis type 2</a> (NF2) causes <a href=\"http://www.nidcd.nih.gov/health/hearing/acoustic_neuroma.asp\" target=\"_blank\">acoustic neuromas</a>; hearing loss; ringing in the ears; poor balance; brain and/or spinal tumors; and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001001.htm\" target=\"_blank\">cataracts</a> at a young age. It often starts in the teen years.\r\n    </li>\r\n</ul>\r\n<ul>\r\n    <li><a href=\"http://rarediseases.info.nih.gov/GARD/Condition/4768/Schwannomatosis.aspx\" target=\"_blank\">Schwannomatosis</a> causes <a href=\"http://rarediseases.info.nih.gov/gard/4767/schwannoma/resources/1\" target=\"_blank\">schwannomas</a>, pain, numbness, and&nbsp;weakness. It is the rarest type. </li>\r\n</ul>\r\nAll three types of NF are inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. There is no cure for NF. Treatment is aimed at controlling symptoms and may include surgery to remove tumors, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001918.htm\" target=\"_blank\">radiation therapy</a>, and/or medicines.[2019][7942]","dateModified":"2017-02-16T00:00:00"},"basicQuestions":[{"questionId":3020,"questionText":"Is neurofibromatosis inherited?","answerText":"Neurofibromatosis is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner.[7943] This means that to be affected, a person only needs a change (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>) in one copy of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a> in each cell. In some cases, an affected person inherits the mutation from an affected parent. Other cases may result from new (<a href=\"http://www.ghr.nlm.nih.gov/glossary=denovomutation\" target=\"_blank\">de novo</a>) mutations in the gene. These cases occur in people with no history of the disorder in their family. A person with neurofibromatosis has a 50% chance with each pregnancy of passing along the altered gene to his or her child.","dateModified":"2015-07-27T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7943,"authors":"","articleTitle":"Learning About Neurofibromatosis","bookWebsiteJournalTitle":"National Human Genome Research Institute","date":"March 2014","volume":"","pages":"","url":"http://www.genome.gov/14514225","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":8606,"authors":"Evans DG","articleTitle":"Neurofibromatosis type 2","bookWebsiteJournalTitle":"UpToDate","date":"August 3, 2016","volume":"","pages":"","url":"http://www.uptodate.com/contents/neurofibromatosis-type-2","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8607,"authors":"Korf BR","articleTitle":"Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"June 19, 2015","volume":"","pages":"","url":"http://www.uptodate.com/contents/neurofibromatosis-type-1-nf1-pathogenesis-clinical-features-and-diagnosis","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":5408,"relatedDiseaseName":"Chromosome 17q11.2 deletion syndrome","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10543,"relatedDiseaseName":"Duodenal carcinoid syndrome","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3967,"relatedDiseaseName":"Multiple café-au-lait spots","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":7866,"relatedDiseaseName":"Neurofibromatosis type 1","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":7193,"relatedDiseaseName":"Neurofibromatosis type 2","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":372,"relatedDiseaseName":"Neurofibromatosis-Noonan syndrome","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":4768,"relatedDiseaseName":"Schwannomatosis","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Neurofibromatosis"}